IS4115A - Ný peptíð - Google Patents

Ný peptíð

Info

Publication number
IS4115A
IS4115A IS4115A IS4115A IS4115A IS 4115 A IS4115 A IS 4115A IS 4115 A IS4115 A IS 4115A IS 4115 A IS4115 A IS 4115A IS 4115 A IS4115 A IS 4115A
Authority
IS
Iceland
Prior art keywords
new peptide
peptide
new
Prior art date
Application number
IS4115A
Other languages
English (en)
Inventor
Schiller Peter
Original Assignee
Ab Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ab Astra filed Critical Ab Astra
Publication of IS4115A publication Critical patent/IS4115A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70—Enkephalins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Transplantation (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IS4115A 1993-01-05 1993-12-27 Ný peptíð IS4115A (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9300012A SE9300012D0 (sv) 1993-01-05 1993-01-05 New peptides

Publications (1)

Publication Number Publication Date
IS4115A true IS4115A (is) 1994-07-06

Family

ID=20388466

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4115A IS4115A (is) 1993-01-05 1993-12-27 Ný peptíð

Country Status (25)

Country Link
US (1) US5602099A (is)
EP (1) EP0678099A1 (is)
JP (1) JPH08505386A (is)
KR (1) KR960700269A (is)
CN (1) CN1096515A (is)
AP (1) AP508A (is)
AU (1) AU681372B2 (is)
CA (1) CA2152380A1 (is)
CZ (1) CZ171195A3 (is)
EE (1) EE9400326A (is)
FI (1) FI953302L (is)
HU (1) HUT72597A (is)
IL (1) IL108169A0 (is)
IS (1) IS4115A (is)
LV (1) LV10962B (is)
MX (1) MX9400255A (is)
NO (1) NO952650L (is)
NZ (1) NZ259597A (is)
PL (1) PL309778A1 (is)
SE (1) SE9300012D0 (is)
SI (1) SI9400005A (is)
SK (1) SK83995A3 (is)
WO (1) WO1994015959A1 (is)
YU (1) YU394A (is)
ZA (1) ZA9455B (is)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854211A (en) * 1993-12-23 1998-12-29 Novo Nordisk A/S Compounds with growth hormone releasing properties
SE9503924D0 (sv) * 1995-08-18 1995-11-07 Astra Ab Novel opioid peptides
IS4261A (is) * 1994-02-21 1995-08-22 Astra Aktiebolag Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra
IL114046A0 (en) * 1994-06-20 1995-10-31 Astra Ab New opioid peptide antagonists
RU2067000C1 (ru) * 1994-06-29 1996-09-27 Владислав Исакович Дейгин Пептид и способ его получения
US6184208B1 (en) 1994-06-29 2001-02-06 Immunotech Developments Inc. Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
SE9402880D0 (sv) * 1994-08-30 1994-08-30 Astra Ab New peptide derivatives
US5780589A (en) * 1994-11-30 1998-07-14 The United States Of America As Represented By The Department Of Health And Human Services Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof
EP0837875A4 (en) * 1995-03-29 1998-10-07 Merck & Co Inc INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
EP0837857A4 (en) * 1995-03-29 1998-08-05 Merck & Co Inc Inhibitors of farnesyl-protein transferase
DE19512484A1 (de) 1995-04-04 1996-10-17 Bayer Ag Kohlenhydratmodifizierte Cytostatika
SE9600769D0 (sv) * 1996-02-28 1996-02-28 Astra Ab Compounds useful as analgesic
EP1001764A4 (en) * 1997-05-29 2005-08-24 Merck & Co Inc HETEROCYCLIC AMIDE COMPOUNDS AS INHIBITORS OF CELL ADHESION
US6903075B1 (en) 1997-05-29 2005-06-07 Merck & Co., Inc. Heterocyclic amide compounds as cell adhesion inhibitors
US6703381B1 (en) * 1998-08-14 2004-03-09 Nobex Corporation Methods for delivery therapeutic compounds across the blood-brain barrier
US6306576B1 (en) * 1999-02-19 2001-10-23 Cleveland Clinic Foundation Diagnostic methods for asthma
US7601739B2 (en) 2003-08-08 2009-10-13 Virgina Commonwealth University Compounds having antiestrogenic and tissue selective estrogenic properties, and compounds with anti-androgenic properties for treatment of prostate cancer and androgen receptor dependent diseases
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
US20060069086A1 (en) * 2004-09-23 2006-03-30 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
US20080045610A1 (en) * 2004-09-23 2008-02-21 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
EP3160497A4 (en) * 2014-06-27 2018-01-17 H. Lee Moffitt Cancer Center And Research Institute, Inc. Conjugates for immunotherapy

Also Published As

Publication number Publication date
WO1994015959A1 (en) 1994-07-21
YU394A (sh) 1997-07-31
LV10962B (en) 1997-04-20
FI953302A7 (fi) 1995-07-04
US5602099A (en) 1997-02-11
MX9400255A (es) 1994-07-29
NZ259597A (en) 1996-07-26
AP9400605A0 (en) 1994-01-31
CN1096515A (zh) 1994-12-21
HUT72597A (en) 1996-05-28
LV10962A (lv) 1995-12-20
AU5844894A (en) 1994-08-15
CA2152380A1 (en) 1994-07-21
AP508A (en) 1996-07-22
ZA9455B (en) 1994-07-05
EP0678099A1 (en) 1995-10-25
EE9400326A (et) 1996-04-15
SI9400005A (en) 1994-12-31
PL309778A1 (en) 1995-11-13
FI953302A0 (fi) 1995-07-04
NO952650L (no) 1995-08-30
KR960700269A (ko) 1996-01-19
NO952650D0 (no) 1995-07-04
IL108169A0 (en) 1994-04-12
SE9300012D0 (sv) 1993-01-05
CZ171195A3 (en) 1996-09-11
SK83995A3 (en) 1996-09-04
JPH08505386A (ja) 1996-06-11
AU681372B2 (en) 1997-08-28
HU9502041D0 (en) 1995-09-28
FI953302L (fi) 1995-07-04

Similar Documents

Publication Publication Date Title
FI943084A7 (fi) Uusia sulfonyyliaminopyrimidiinejä
FI965225L (fi) Uusia peptidejä
DE69432420D1 (de) Bohrgestängeanordnung
FI961350A7 (fi) Hapteenimerkityt peptidit
DK6893D0 (da) Peptid
FI951330A0 (fi) Sihti
LV10962A (lv) Jauni peptidi
NO953270D0 (no) Fibrinogenreceptorantagonister
FI940109A0 (fi) Peptidejä
ATA146094A (de) Windsichter
FI970168L (fi) Peptidejä
FI964363L (fi) Peptidejä
DE69427363D1 (de) Plättchenaggregationsinhibierende peptide
BR9606756A (pt) Peptídeo
NO981052D0 (no) Peptidderivater
NO981051D0 (no) Peptidderivater
FIU930217U0 (fi) Maet- och transmitterapparat
FI931646A0 (fi) Runko-ohjausniveljärjestely
SE9504467D0 (sv) Peptide
BR1100812A (pt) Peptìdeo
KR940024089U (ko) 개량수저
KR950006157U (ko) 개량 불바
ITRC930003A0 (it) Ecomat c
FI835U1 (fi) Staellningshaengsel
FI964U1 (fi) Maskkompostor